SABC public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
SABC North West

SABC News and Current Affairs

Unsubscribe
Unsubscribe
Monthly
 
Sabc News North West provides a platform that extends news coverage beyond television and radio. It adds to the presence of the SABC News brand on digital platforms to be on par with the rest of the world. The news are generated SABC journalists in the North West province but is not limited to the province. Our footprint spreads across several provinces and our stories reflect as such.
  continue reading
 
Ikwekwezi FM Education Programs serve to delivering on the educational mandate of the public broadcaster (SABC). In true South African social tradition, Ikwekwezi FM Education Programs meet this challenge by delivering compelling educational content for diverse audiences in South Africa. The education content, gathered from a wide range of educational issues contributes to a rich cultural shared South African identity. Enriching Minds, Enriching Lives!
  continue reading
 
Artwork
 
Born S’phamandla Mhlongo on 13th June 1989, MarazA is a South African musician, producer, writer, and TV maker. His main musical forte is Hip Hop and Alternative Rap (including Electronic), although he has become known for his versatility and flexibility. He is a former battle champion, having participated in and won the Jam Alley Versus Competition, The KZN leg of the Halls BeatBox Choir, and the South African Leg of Channel O MC Africa 2, of which he was the RSA champion and came third in ...
  continue reading
 
We're Donald Monat and June Dixon, two writer-producer-performers whose professional work together has taken them to three different continents in more than fifty years of constant production for the theatre, radio, television, film and the simple, printed word. Our podcast, The Monat-Dixon Line includes contemporary comment and samples of many aspects of our work including satirical comedy sketches … original songs from musical shows we helped to create … and excerpts from some of our radio ...
  continue reading
 
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
  continue reading
 
The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com
  continue reading
 
Billionaires in Boxers TV (BiBtv) The Global Entrepreneur Network. Billionaire’s in Boxers. Stay Remote, Stay Global. Join us Mondays, Wednesdays, and Fridays, live across Africa and online globally. Hosts Phil Pelucha & Justin Kotze, leaders of Billionaires in Boxers media, interview global experts to provide their audience with actionable steps to take control of their financial freedom. The ability to work from wherever you want, whenever you want. Join the Remote Working Revolution for i ...
  continue reading
 
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
  continue reading
 
Artwork
 
Welcome. You're probably here 'cause you're looking to get away and have a little laugh. I'll do you one better, I'll also let you in on what's happening in the (music) news at the same time. So since you're here already, Why Don't We Hang?😁
  continue reading
 
Loading …
show series
 
Guest: Robert Motl, PhD Rehabilitation training for multiple sclerosis patients aims to improve mobility, cognitive function, and quality of life. But one of the largest barriers to having more high-quality randomized control trials of rehabilitation in MS is that most researchers could not be following a stage of different research approaches. So …
  continue reading
 
This week, we cover interesting research from TTLC 2024, focusing on innovative treatments for lung cancer. Starting off, Bruna Pellini from Moffitt Cancer Center, FL, talks about the utility of circulating tumor DNA as a biomarker of progression in lung cancer, her latest findings from notable Phase III trials and ongoing studies looking into incr…
  continue reading
 
Guest: Marisa McGinley, DO The amount of patients being diagnosed with neurological conditions and multiple sclerosis (MS) is a growing number, which causes a need for more neurologists, MS specialists, and better access to care. A potential advantage of using technology in MS care would be to break down the geographic barrier. To learn more about …
  continue reading
 
Guest: Yinan Zhang, MD Chronological age is the biggest early driver of disease progression in patients with multiple sclerosis (MS). That’s why a team of researchers wanted to explore whether biomarkers like p16 and the epigenetic clock can be used to assess biological aging in patients with MS. They found that while patients with MS are aging fas…
  continue reading
 
Invasive lobular carcinoma (ILC) poses unique challenges in breast cancer management. Its subtle presentation and distinct biological behavior demand a nuanced approach from healthcare professionals. In this podcast, we delve into the epidemiology, pathology, diagnostic methods, treatment modalities, and emerging research surrounding ILC. By compre…
  continue reading
 
In this podcast, we will discuss key insights from the 2024 ASCO Gastrointestinal (GI) Cancers Symposium held in San Francisco, CA. Topics include updates in the KEYNOTE-811, MATTERHORN, and CheckMate 649 trials, as well as the use of circulating free DNA analysis in esophagogastric cancer and the evolving landscape of treatment of HER2-positve met…
  continue reading
 
- Why Chemotherapy Causes Treatment Side Effects & Discomfort- Working with Your Healthcare Team to Better Understand & Cope with Potential Treatment Side Effects with a Plan to Manage or Prevent Them - Common Treatment Gastrointestinal (GI) Side Effects - You May Not Experience All of These - Loss of Appetite, Nausea, Vomiting, Mouth Sores, Stomat…
  continue reading
 
Host: Rishi Sekar, MD A recent study sought to investigate why there are disparities in mortality as well as access and participation in clinical trials among vulnerable prostate cancer populations. According to the findings, counties in the United States that had the highest prostate cancer mortality were less likely to have any clinical trials in…
  continue reading
 
- Overview and Definition of Biomarkers- What Are Some Examples of Biomarker Testing- How Biomarker Testing Provides Useful Information for Cancer Treatment - Why the Molecular Portrait of Cancer Is So Important- The Role of the Pathologist- Benefits of Biomarker Testing & Precision Medicine- Predicting Response to Treatment- Clinical Trials: How R…
  continue reading
 
- Unique Needs of Young Adult Cancer Survivors- Identity, Relationships & Intimacy- Dating- Couples/Partners Dealing with Survivorship- Communicating about Sex- Sexuality & Intimacy- Sex Drive: Ability & Desire- Tips to Deal with Vaginal Dryness, Premature Menopause, Erectile Dysfunction, Premature Ejaculation & Sperm Banking- Low Desire: How to Ge…
  continue reading
 
In this podcast, we will discuss key insights from the 2024 ASCO Genitourinary (GU) Cancers Symposium held in San Francisco, CA. Topics include updates in the AMBASSADOR, CONTACT-2, and CLEAR trials, as well as why BCG-unresponsive patients with non-muscle invasive bladder cancer refuse cystectomy and the emerging role transperineal prostate biopsi…
  continue reading
 
Host: Zachery Reichert MD, PhD If hormonal therapies are not working for prostate cancer patients, chemotherapy may be a reliable alternative based on findings from a recent study. In fact, out of the 70 percent of patients who had pain when entering the study, 45 percent had their pain improved with chemotherapy. Dive more into the findings with D…
  continue reading
 
- Overview of Breast Cancer in Younger Women, Including Diagnosing, Staging- ER, PR & HER2 Status- Unique Issues for Younger Women Living with Breast Cancer- Precision Medicine & Sequencing of Treatment- Biomarker Testing & Genetic Testing, Including BRCA Testing- What Informs Treatment Decisions & Options: Understanding Your Pathology Report- Upda…
  continue reading
 
In this podcast, we’ll be covering highlights from the PROCSA/BLADDR 2023 Meeting, which took place in Valencia, Spain, such as the evolution of targeted therapies and novel biomarker driven studies in prostate cancer, as well as trimodal therapy for non-muscle invasive bladder cancer. Hear from Rob Jones (The University of Glasgow, Glasgow, UK), B…
  continue reading
 
The recent European Society for Medical Oncology (ESMO) Asia 2023 Congress in Singapore, brought together key oncology experts to delve into the latest oncology advancements. In this podcast episode, we are honored to host discussions with distinguished guests: Enrique Grande (MD Anderson Cancer Centre Madrid, Madrid, Spain), Molly Li (Queen Elizab…
  continue reading
 
Host: Daniel Kwon, MD Between patient anxiety and insurance implications, there are several challenges associated with delivering germline testing to veterans with advanced prostate cancer. Learn more about these challenges and proposed solutions with Dr. Daniel Kwon, who presented the “Challenges in Patient-Centered Germline Testing Delivery for V…
  continue reading
 
Guest: Jessica E. Hawley M.D. M.S. The National Comprehensive Cancer Network (NCCN) has recommended new guidelines for the treatment of prostate Cancer. In this episode, you’ll learn about the top three biggest changes to the NCCN guidelines. Tune in with Dr. Jessica Hawley, Assistant Professor in the Division of Hematology and Oncology at the Univ…
  continue reading
 
Host: Neal Shore, MD Between 20 and 50 percent of patients with high-risk localized prostate cancer will develop biochemical resistance, but historically, no Level I evidence for treatment was available. That’s why the EMBARK study is the first phase 3 trial to develop Level I evidence looking at monotherapy T suppression versus monotherapy enzalut…
  continue reading
 
Loading …

Quick Reference Guide